nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefradine—SLC22A5—Dactinomycin—testicular cancer	0.613	0.613	CbGbCtD
Cefradine—SLC22A6—Methotrexate—testicular cancer	0.13	0.13	CbGbCtD
Cefradine—CYP3A4—Ifosfamide—testicular cancer	0.11	0.11	CbGbCtD
Cefradine—CYP3A4—Vinblastine—testicular cancer	0.0584	0.0584	CbGbCtD
Cefradine—CYP3A4—Etoposide—testicular cancer	0.0526	0.0526	CbGbCtD
Cefradine—CYP3A4—Doxorubicin—testicular cancer	0.0359	0.0359	CbGbCtD
